Petros Pharmaceuticals, Inc. (PTPI)
NASDAQ: PTPI · Real-Time Price · USD
0.0691
-0.0169 (-19.65%)
At close: Mar 31, 2025, 4:00 PM
0.0710
+0.0019 (2.75%)
After-hours: Mar 31, 2025, 5:52 PM EDT
Petros Pharmaceuticals Market Cap
Petros Pharmaceuticals has a market cap or net worth of $2.07 million as of March 31, 2025. Its market cap has decreased by -34.52% in one year.
Market Cap
2.07M
Enterprise Value
6.02M
1-Year Change
-34.52%
Ranking
Category
Stock Price
$0.07
Market Cap Chart
Since December 2, 2020, Petros Pharmaceuticals's market cap has decreased from $38.73M to $2.07M, a decrease of -94.66%. That is a compound annual growth rate of -49.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 2.57M | -34.75% |
| Dec 31, 2024 | 3.94M | 27.11% |
| Dec 29, 2023 | 3.10M | -35.68% |
| Dec 30, 2022 | 4.82M | -92.98% |
| Dec 31, 2021 | 68.71M | 60.87% |
| Dec 31, 2020 | 42.71M | 10.27% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |